Physician profile
Jaime Aburto
NPI 1366696072
$3,059.72
in general payments reported to CMS, 2019-2025
13 companies · $586 in 2025
The $586 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $666 · 2021: $322 · 2022: $229 · 2023: $903 · 2024: $187 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,350 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,350.17 |
| Long Term Medical Supply Or Device Loan | $326.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $989.15 | 2021-2025 | Integra, Durasorb Monofilament Mesh, Surgimend |
| Mentor Worldwide LLC | $720.41 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Kerecis Limited | $361.98 | 2019-2021 | |
| Abbvie INC. | $245.33 | 2022-2025 | Natrelle Saline-Filled Breast Implants |
| Musculoskeletal Transplant Foundation INC. | $124.56 | 2020 | |
| Medline Industries LP | $122.01 | 2023-2025 | |
| Avanos Medical | $116.18 | 2021-2025 | On-Q Pump and Accessories |
| Vertex Pharmaceuticals Incorporated | $114.70 | 2025 | |
| Davol INC. | $86.83 | 2020 | |
| Allergan, INC. | $70.30 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $67.27 | 2019-2025 | Exparel |
| Baxter Healthcare | $24.73 | 2025 | Perclot |
| Solventum Corporation | $16.27 | 2025 | Prevena, Activ.A.C. Ion Progress, Promogran Prisma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Aburto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.